Author:
Mediwala Sanjay N.,Sun Huiying,Szafran Adam T.,Hartig Sean M.,Sonpavde Guru,Hayes Teresa G.,Thiagarajan Perumal,Mancini Michael A.,Marcelli Marco
Funder
VA Merit Review Program
DOD Prostate Cancer Res Program
South Central VA Health Care Network (VISN 16) Research Grant
Helis Foundation
John S. Dunn Gulf Coast Consortium for Chemical Genomics (MA Mancini).
Diabetes & Endocrinology Research
Imaging resources were supported by BW O'Malley
MK Estes
CK Osborne
The Dan L. Duncan Cancer Center of Baylor College of Medicine and
Reference51 articles.
1. Cancer statistics, 2011: The impact of eliminating socioeconomic and racial disparities on premature cancer deaths;Siegel;CA: A Cancer Journal For Clinicians,2011
2. Disruption of androgen receptor function inhibits proliferation of androgen-refractory prostate cancer cells;Zegarra-Moro;Cancer Res,2002
3. Molecular determinants of resistance to antiandrogen therapy;Chen;Nat Med,2004
4. Beefing up prostate cancer Therapy with performance-enhancing (anti-) steroids;Nelson;Cancer Cell,2011
5. Splicing of a novel androgen receptor exon generates a constitutively active androgen receptor that mediates prostate cancer therapy resistance;Dehm;Cancer Res,2008
Cited by
51 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献